Reply to A. Ruggiero et al. to our article 'Impact of the French COVID-19 pandemic lockdown on newly diagnosed melanoma delay and severity'

Rafaele Molinier¹, Anissa Roger^{1

2}, Bastien Genet³, Philippe Saiag^{1

2}, Elisa Funck-Brentano^{1

2}

Affiliations

¹ Department of General and Oncologic Dermatology, Ambroise-Paré Hospital, AP-HP, Boulogne-Billancourt, France.
² Research Unit EA4340 "Biomarkers and Clinical Trials in Oncology and Onco-Hematology", Versailles-Saint-Quentin-en-Yvelines University, Paris-Saclay University, 91190, France.
³ Department of Statistics and Methodology on Biomedical Research, Kremlin-Bicêtre University, Paris-Saclay University, 91190, France.

Comment

Rafaele Molinier et al. J Eur Acad Dermatol Venereol. 2023 Jan.

. 2023 Jan;37(1):e20-e21.

doi: 10.1111/jdv.18542. Epub 2022 Aug 29.

Rafaele Molinier¹, Anissa Roger^{1

2}, Bastien Genet³, Philippe Saiag^{1

2}, Elisa Funck-Brentano^{1

2}

¹ Department of General and Oncologic Dermatology, Ambroise-Paré Hospital, AP-HP, Boulogne-Billancourt, France.
² Research Unit EA4340 "Biomarkers and Clinical Trials in Oncology and Onco-Hematology", Versailles-Saint-Quentin-en-Yvelines University, Paris-Saclay University, 91190, France.
³ Department of Statistics and Methodology on Biomedical Research, Kremlin-Bicêtre University, Paris-Saclay University, 91190, France.

No abstract available

Conflict of interest statement

All authors have declared no conflicts of interest.

Reply to 'Impact of the French COVID-19 pandemic lockdown on newly diagnosed melanoma delay and severity' by R. Molinier et al.
Ruggiero A, Martora F, Fornaro F, Scalvenzi M, Fabbrocini G, Villani A. Ruggiero A, et al. J Eur Acad Dermatol Venereol. 2023 Feb;37(2):e130-e131. doi: 10.1111/jdv.18512. Epub 2022 Aug 20. J Eur Acad Dermatol Venereol. 2023. PMID: 35972812 Free PMC article. No abstract available.

1. Ruggiero A, Martora F, Fornaro F, Scalvenzi M, Fabbrocini G, Villani A. Reply to “Impact of the French COVID‐19 pandemic lockdown on newly diagnosed melanoma delay and severity” by R. Molinier et al. J Eur Acad Dermatol Venereol. 2022. 10.1111/jdv.18512 - DOI - PMC - PubMed
1. Molinier R, Roger A, Genet B, Blom A, Longvert C, Chaplain L, et al. Impact of the French COVID‐19 pandemic lockdown on newly diagnosed melanoma delay and severity. J Eur Acad Dermatol Venereol JEADV. 2022;36:e164–6. - PMC - PubMed
1. Ricci F, Abeni D. Heterogeneity of reports about the impact of the COVID‐19 pandemic on melanoma diagnosis. Br J Dermatol. 2022;187:135–6. - PMC - PubMed
1. Gualdi G, Porreca A, Amoruso GF, Atzori L, Calzavara‐Pinton P, de Tursi M, et al. The effect of the COVID‐19 lockdown on melanoma diagnosis in Italy. Clin Dermatol. 2021;39:911–9. - PMC - PubMed
1. Scharf C, Brancaccio G, Di Stefani A, Fargnoli MC, Kittler H, Kyrgidis A, et al. The association between COVID‐19 lockdowns and melanoma diagnosis and thickness: a multicenter retrospective study from Europe. J Am Acad Dermatol. 2022;87:648–9. - PMC - PubMed